These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Hormonal and metabolic disorders in Itsenko-Cushing's syndrome]. Sazonov AM, Luk'ianchikov VS, Kalinin AP, Balabolkin MI, Bogatyrev OP. Ter Arkh; 1975; 47(1):90-6. PubMed ID: 163504 [No Abstract] [Full Text] [Related]
23. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Leal-Cerro A, Torres E, Soto A, Dios E, Deghenghi R, Arvat E, Ghigo E, Dieguez C, Casanueva FF. Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947 [Abstract] [Full Text] [Related]
24. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A, Murray RD, Teasdale GM, Shalet SM. Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [Abstract] [Full Text] [Related]
25. [Neurohumoral regulation of gastric secretion in postvagotomy syndromes]. Khalmuratova RA, Sativoldyev MM, Arutiunova MV. Khirurgiia (Mosk); 1994 Jun; (6):28-30. PubMed ID: 7933883 [Abstract] [Full Text] [Related]
26. [Relations between insulin, somatotropic hormone and somatostatin secretions in patients with ischemic heart disease]. Titov VN, Kazimov RG, Kasatkina LV, Masenko VP, Beznosenko SA. Kardiologiia; 1983 Jun; 23(6):91-4. PubMed ID: 6136624 [Abstract] [Full Text] [Related]
29. [Influence of verapamil on blood sugar and insulin secretion after intravenous administration of glucose and on somatotropin secretion after insulin stimulation]. Petralito A, Lunetta M, Fiore CE, Liuzzo A, Giuga G. Boll Soc Ital Cardiol; 1978 Jun; 23(2):404-11. PubMed ID: 754799 [No Abstract] [Full Text] [Related]